Trade IONS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Ionis Pharmaceuticals, Inc. (IONS) is trading at US$44.44, down 4.94% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$9.93B. Over the past 52 weeks, IONS has traded between US$44.27 and US$86.74. On Syfe you can trade IONS with $0 commission and add it to your watchlist.
| Previous close | US$46.75 |
|---|---|
| Market cap | US$9.93B |
| 52-week range | US$44.27 – US$86.74 |
| Volume | 7.31M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Year: 1991
Ionis Pharmaceuticals Insider Bought Shares Worth $1,058,700, According to a Recent SEC Filing
Jul 31, 8:50 PM · MT Newswires
Ionis Pharmaceuticals, Inc. (IONS) stock is trading at US$44.44, -4.94% from the previous close of US$46.75.
The market cap for Ionis Pharmaceuticals, Inc. (IONS) stock is approximately US$9.93B.
The 52-week high for Ionis Pharmaceuticals, Inc. (IONS) stock is US$86.74.
The 52-week low for Ionis Pharmaceuticals, Inc. (IONS) stock is US$44.27.
Ionis Pharmaceuticals, Inc. (IONS) does not currently pay a dividend.
Stay on top of IONS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
